3 ms·
bullshit. the big bad pharmaceutical industry is full of biotech startups that all race to find something new. it is not a monolithic cabal of lizard people.
by pinaceae 12y ago
bullshit.
the big bad pharmaceutical industry is full of biotech startups that all race to find something new. it is not a monolithic cabal of lizard people.
like this:
http://www.npr.org/blogs/health/2013/12/24/256839330/orenitram-united-therapeutics-names-pill-after-ceo-who-sought-daughters-cure http://www.npr.org/blogs/health/2013/12/24/256839330/orenitr...
the pharma industry cares more about the well-being of its customers than most of the companies HN usually covers. now go back to coding your mobile/social/dating app that actually cares about the well being of anyone.
opposition to pharma, opposition to vaccines, opposition to science.
- pjonesdotca 12y agoThis tho: Orenitram won't be available for sale for about six months, the company said, and its exact price hasn't been determined either. But it will be very expensive, about $150,000 a year, according to an estimate by Dr. Mark Schoenebaum, an industry analyst with ISI. $150k/yr? Is that really necessary?
- snikeris 12y agoYes. The R/D is expensive and there are many more failed drugs than those that make it to market.
- pinaceae 12y agoyes, it needs to cover the cost in development and getting it through approval. however, this also establishes a market - a competitor will now either come with something cheaper or something better (for the same or higher price). same thing is happening with Hep-C, which is now curable (boo, bad pharma). initial drug was/is super expensive, record profits for the company. every single contender is driving the price down. and there contenders as the market has been proven. this is the capitalist system at work, in full glory. even with patents in play. amazing shit right there.